All News

Found 2,769 articles

• Zestra Laboratories, Inc. Completes Enrollment Of Its Clinical Trial In 200 Women With Mixed Sexual Dysfunction

  11/7/2006

• Cell Therapeutics, Inc. Temporarily Suspends Enrollment On PIONEER Lung Cancer Clinical Trial; Current Patients Continue To Be Treated

  11/6/2006

• EntreMed, Inc. Commences Phase 2 Clinical Trial With Panzem(R) NCD In Ovarian Cancer

  11/1/2006

• VIVUS, Inc. Appoints Changjin (CJ) Wang, Ph.D. As Vice President Of Business Development

  11/1/2006

• Bionovo, Inc.'s Phase 1/2 Clinical Trial Protocol For Metastatic Breast Cancer Accepted By FDA

  10/31/2006

• VIVUS, Inc. Reports Third Quarter 2006 Financial Results

  10/27/2006

• Wyeth Presents Data On A Tissue Selective Estrogen Complex Class For Menopausal Therapy

  10/26/2006

• Twin Ovary Transplant Successes

  10/25/2006

• VIVUS, Inc. Says Diet Drug Effective In Mid-Stage Study

  10/23/2006

• Obese Post-Menopausal Women Prone To Breast Cancer: Studies

  10/23/2006

• Natrol Acquires U.S. Rights To Promensil(R) And Trinovin(R) Brands From Novogen Limited

  10/23/2006

• VIVUS, Inc. Announces The Presentation Of Phase 2 Data For Qnexa(TM) At The North American Association For The Study Of Obesity (NAASO) 2006 Annual Scientific Meeting

  10/20/2006

• VIVUS, Inc. Announces Third Quarter 2006 Financial Results Conference Call

  10/20/2006

• PharmaNova Grants Exclusive U.S. License To Depomed, Inc. For Extended Release Gabapentin Use In Hot Flashes

  10/19/2006

• Bionovo, Inc. Completes Enrollment Of MF101 Phase 2 Trial To Evaluate A Safer, New Therapy For Menopausal Symptoms

  10/18/2006

• Depomed, Inc. Obtains Exclusive License To Gabapentin Use In Hot Flashes

  10/18/2006

• BioSante Pharmaceuticals, Inc. Presents Bio-E-Gel(R) Woman-To-Partner Transfer Study At Menopause Society Meeting

  10/12/2006

• VIVUS, Inc. To Present At The Biotechnology Industry Organization (BIO) InvestorForum

  10/12/2006

• Synovis Life Technologies, Inc. Signs Agreement With Caldera Medical

  10/11/2006

• BioSante Pharmaceuticals, Inc. Presents Bio-E-Gel(R) Data At North American Menopause Society Meeting

  10/11/2006